NCT00215163View on ClinicalTrials.gov

Paroxetine-CR to Treat Post-Traumatic Stress Disorder (PTSD) Symptomatic After Initial Exposure Therapy

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

17

Participants

Timeline

Start Date

December 31, 2002

Study Completion Date

June 30, 2006

Conditions

Stress Disorders, Post-Traumatic

Interventions

DRUG

Cognitive-behavioral therapy and paroxetine-CR

Trial Locations (4)

19122

University of Pennsylvania, Philadelphia

27705

Duke University Medical Center, Durham

92093

University of California at San Diego, San Diego

02114

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

Duke University

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Massachusetts General Hospital

OTHER

lead

Duke University

OTHER